JP2001519410A5 - - Google Patents

Download PDF

Info

Publication number
JP2001519410A5
JP2001519410A5 JP2000515866A JP2000515866A JP2001519410A5 JP 2001519410 A5 JP2001519410 A5 JP 2001519410A5 JP 2000515866 A JP2000515866 A JP 2000515866A JP 2000515866 A JP2000515866 A JP 2000515866A JP 2001519410 A5 JP2001519410 A5 JP 2001519410A5
Authority
JP
Japan
Prior art keywords
formula
embedded image
ring
alkyl
compound represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000515866A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001519410A (ja
Filing date
Publication date
Priority claimed from US09/161,653 external-priority patent/US6005102A/en
Application filed filed Critical
Priority claimed from PCT/US1998/021609 external-priority patent/WO1999019293A1/en
Publication of JP2001519410A publication Critical patent/JP2001519410A/ja
Publication of JP2001519410A5 publication Critical patent/JP2001519410A5/ja
Pending legal-status Critical Current

Links

JP2000515866A 1997-10-15 1998-10-14 新規なアリールオキシ−アルキル−ジアルキルアミン Pending JP2001519410A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US95081897A 1997-10-15 1997-10-15
US08/950,818 1997-10-15
US09/161,653 US6005102A (en) 1997-10-15 1998-09-28 Aryloxy-alkyl-dialkylamines
US09/161,653 1998-09-28
PCT/US1998/021609 WO1999019293A1 (en) 1997-10-15 1998-10-14 Novel aryloxy-alkyl-dialkylamines

Publications (2)

Publication Number Publication Date
JP2001519410A JP2001519410A (ja) 2001-10-23
JP2001519410A5 true JP2001519410A5 (https=) 2006-03-16

Family

ID=26858006

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000515866A Pending JP2001519410A (ja) 1997-10-15 1998-10-14 新規なアリールオキシ−アルキル−ジアルキルアミン

Country Status (26)

Country Link
EP (2) EP1777214A3 (https=)
JP (1) JP2001519410A (https=)
KR (1) KR100669836B1 (https=)
CN (1) CN1231458C (https=)
AR (1) AR015183A1 (https=)
AT (1) ATE355264T1 (https=)
AU (1) AU757630C (https=)
BR (1) BR9813069A (https=)
CA (1) CA2306343C (https=)
CY (1) CY1106497T1 (https=)
DE (1) DE69837210T2 (https=)
DK (1) DK1025077T3 (https=)
EA (1) EA003937B1 (https=)
EE (1) EE200000225A (https=)
ES (1) ES2281937T3 (https=)
HU (1) HUP0004419A3 (https=)
ID (1) ID24417A (https=)
IL (2) IL135343A0 (https=)
NO (1) NO20001938L (https=)
NZ (1) NZ503793A (https=)
PL (1) PL198443B1 (https=)
PT (1) PT1025077E (https=)
SI (1) SI1025077T1 (https=)
SK (1) SK286460B6 (https=)
TR (1) TR200001012T2 (https=)
WO (1) WO1999019293A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA005932B1 (ru) * 1998-05-15 2005-08-25 Уайт 2-фенил-1-[4-(2-аминоэтокси)бензил]индол в комбинации с эстрогенами
US6479535B1 (en) 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
CA2382683A1 (en) * 1999-09-13 2001-03-22 American Home Products Corporation Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-¬4-(2-amin-1-yl-ethoxy)-benzyl|-1h-indol-5-ols
US6455568B2 (en) 2000-07-06 2002-09-24 Wyeth Combination therapy for inhibiting sphincter incontinence
AR029538A1 (es) 2000-07-06 2003-07-02 Wyeth Corp Composiciones farmaceuticas de agentes estrogenicos
AU2001273144A1 (en) 2000-07-06 2002-01-21 Wyeth Use of substituted indole compounds for treating neuropeptide y-related conditions
MXPA03000170A (es) 2000-07-06 2003-05-27 Wyeth Corp Combinaciones de un inhibidor de recaptacion de serotonina selectivo y agentes estrogenicos.
AR029539A1 (es) 2000-07-06 2003-07-02 Wyeth Corp Combinaciones de estatinas y agentes estrogenicos
EP1656938A1 (en) 2000-07-06 2006-05-17 Wyeth Combinations of SSRI and estrogenic agents
WO2002003990A2 (en) 2000-07-06 2002-01-17 Wyeth Use of substituted insole compounds for treating excessive intraocular pressure
US6376486B1 (en) 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
US6369051B1 (en) 2000-07-06 2002-04-09 American Home Products Corporation Combinations of SSRI and estrogenic agents
JP2004532834A (ja) * 2001-03-23 2004-10-28 イーライ・リリー・アンド・カンパニー ヒスタミンｈ３受容体アンタゴニストである非イミダゾール系アリールアルキルアミン化合物、その製造および治療的使用
JP2004531559A (ja) 2001-05-22 2004-10-14 イーライ・リリー・アンド・カンパニー エストロゲン欠乏または内因性エストロゲンに対する異常な生理反応に関連する疾患を抑制するためのテトラヒドロキノリン誘導体
EP1395563B1 (en) 2001-05-22 2006-03-29 Eli Lilly And Company 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
US7314937B2 (en) 2002-03-21 2008-01-01 Eli Lilly And Company Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses
US7098241B2 (en) 2002-12-16 2006-08-29 Hoffmann-La Roche Inc. Thiophene hydroxamic acid derivatives
WO2005100316A1 (en) 2004-04-07 2005-10-27 Wyeth Crystalline polymorph of a bazedoxifene acetate
JP2007532548A (ja) 2004-04-07 2007-11-15 ワイス バゼドキシフェンアセテートの結晶質多形体
MXPA06011686A (es) 2004-04-08 2006-12-14 Wyeth Corp Ascorbato de bazedoxifeno como modulador del receptor de estrogeno selectivo.
JP2008509148A (ja) * 2004-08-05 2008-03-27 ワイス 塩酸ピピンドキシフェン一水和物の結晶多形
EP1836155A2 (en) * 2005-01-13 2007-09-26 Wyeth, A Corporation of the State of Delaware Processes for the preparation of aminoethoxybenzyl alcohols
US20100087661A1 (en) * 2007-02-12 2010-04-08 Josef Jirman Method for the preparation of 5-benzyloxy-2-(4-benzyloxphenyl)-3-methyl-1h-indole
WO2009102771A1 (en) * 2008-02-11 2009-08-20 Wyeth Methods of converting polymorphic form b of bazedoxifene acetate to polymorphic form a of bazedoxifene acetate
CA2758109A1 (en) * 2009-04-13 2010-10-21 Sandoz Ag Processes for the synthesis of bazedoxifene acetate and intermediates thereof
US8569483B2 (en) 2011-06-21 2013-10-29 Divi's Laboratories, Ltd. Process for the preparation of bazedoxifene acetate and intermediates thereof
CN104151265B (zh) * 2013-05-13 2016-10-05 上海医药工业研究院 醋酸巴多昔芬中间体的制备方法
US9751835B2 (en) 2013-05-15 2017-09-05 Indiana University Research And Technology Corporation Processes and intermediates for preparing indole pharmaceuticals
IT201800006562A1 (it) * 2018-06-21 2019-12-21 Procedimento e intermedi utili per la preparazione di indoli
IT201900001923A1 (it) 2019-02-11 2020-08-11 Erregierre Spa Sali di bazedoxifene utili per la preparazione di bazedoxifene acetato

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH448121A (de) 1963-03-13 1967-12-15 Hoffmann La Roche Verfahren zur Herstellung substituierter Hydrazinverbindungen
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
GB9326332D0 (en) 1993-12-23 1994-02-23 Karo Bio Indole derivatives
CA2259487A1 (en) * 1996-07-01 1998-01-08 Margaret Mary Faul Hypoglycemic and hypolipidemic compounds
YU40999A (sh) * 1997-02-27 2002-06-19 American Cyanamid Company N-hidroksi-2-(alkil,aril ili heteroaril sulfanil,sulfinil ili sulfonil)-3-supstituisani alkil,aril ili heteroarilamidi, kao inhibitori za matrične metaloproteinaze
EP1011666A4 (en) * 1997-04-30 2004-03-31 Lilly Co Eli ANTITHROMBOTIC AGENTS

Similar Documents

Publication Publication Date Title
JP2001519410A5 (https=)
JP2002543183A5 (https=)
JP2004501940A5 (https=)
JP2003501474A5 (https=)
JP2005502658A5 (https=)
JP2002502874A5 (https=)
JP2002508362A5 (ja) １−置換−１−アミノメチル−シクロアルカン誘導体（＝ガバペンチン類縁体）
JP2002508352A5 (ja) ４(３)置換−４(３)−アミノメチル−（チオ）ピラン又はピペリジン誘導体（＝ガバペンチン類似体）
JP2001519443A5 (https=)
JP2001526218A5 (https=)
KR850002469A (ko) 피세나돌 전구체 및 그의 중간체의 제조방법
JP2002539156A5 (https=)
JP2002518502A5 (https=)
JP2002511433A5 (https=)
EP0185324A3 (en) Novel organic trithio oxides and method for the preparation thereof
KR920019777A (ko) 치환된 3-(피리딘일아미노)-인돌 및 벤조[b]티오펜, 이의 제조방법 및 약제로서의 이의 용도
EP1335247A3 (en) Light sensitive composition, light sensitive planographic printing plate precursor, and image formation method
JP2002523496A5 (https=)
JP2005526149A5 (https=)
RU2004107847A (ru) Изоксазолпиридиноны и их применение в лечении болезни паркинсона
KR910000647A (ko) 나프틸아미노-및 나프틸옥시- 피리딘아민 및 관련된 화합물, 이의 제조방법 및 이의 피부소염제로서의 용도
KR880011063A (ko) 프로피올로페논 유도체
JPH1112272A5 (https=)
KR910007923A (ko) 3-(l-피로글루타밀)-l-티아졸리딘-4-카르복실산과 그 유도체의 제조방법
JPH0912569A5 (https=)